Little bit of useful info on the FDA and CDER approval of novel therapies in 2023:
https://www.nature.com/articles/d41573-024-00001-x
Alas Remestemcel-L not amongst them....
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-8299
-
- There are more pages in this discussion • 2,184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
-0.010(1.00%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.0¢ | $6.562M | 6.772M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 34504 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 130352 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 32114 | 0.980 |
11 | 88073 | 0.975 |
13 | 124006 | 0.970 |
10 | 74934 | 0.965 |
13 | 261728 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
0.985 | 20299 | 4 |
0.990 | 84612 | 10 |
0.995 | 65088 | 10 |
1.000 | 122849 | 10 |
1.005 | 192138 | 4 |
Last trade - 12.23pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online